{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:58:26Z","timestamp":1793732306710,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100259"],"award-info":[{"award-number":["82100259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86794-2","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T10:44:27Z","timestamp":1737283467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analyses"],"prefix":"10.1038","volume":"15","author":[{"given":"Ye","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"key":"86794_CR1","unstructured":"Centers for Disease Control and Prevention. Common reproductive health concerns for women. Accessed on May 15, (2024). Available at https:\/\/www.cdc.gov\/reproductive-health\/women-health\/common-concerns.html"},{"key":"86794_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","volume":"62","author":"MV Borght","year":"2018","unstructured":"Borght, M. V. & Wyns, C. Fertility and infertility: Definition and epidemiology. Clin. Biochem. 62, 2\u201310 (2018).","journal-title":"Clin. Biochem."},{"key":"86794_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas, M. & Dunaif, A. Deconstructing a syndrome: Genomic insights into PCOS causal mechanisms and classification. Endocr. Rev. 43, 927\u2013965 (2022).","journal-title":"Endocr. Rev."},{"key":"86794_CR4","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui, S., Mateen, S., Ahmad, R. & Moin, S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J. Assist. Reprod. Genet. 39, 2439\u20132473 (2022).","journal-title":"J. Assist. Reprod. Genet."},{"key":"86794_CR5","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day, F. et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14, e1007813 (2018).","journal-title":"PLoS Genet."},{"key":"86794_CR6","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","volume":"14","author":"L Ottensmann","year":"2023","unstructured":"Ottensmann, L. et al. Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. Nat. Commun. 14, 6934 (2023).","journal-title":"Nat. Commun."},{"key":"86794_CR7","doi-asserted-by":"publisher","first-page":"e03242","DOI":"10.1128\/mBio.03242-19","volume":"11","author":"M Fu","year":"2020","unstructured":"Fu, M. et al. Alterations in vaginal microbiota and associated metabolome in women with recurrent implantation failure. mBio 11, e03242\u2013e03219 (2020).","journal-title":"mBio"},{"key":"86794_CR8","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","volume":"9","author":"J Li","year":"2019","unstructured":"Li, J. et al. Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome. Sci. Rep. 9, 3204 (2019).","journal-title":"Sci. Rep."},{"key":"86794_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale, H. F. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270\u2013284 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"86794_CR10","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/ijms22042165","volume":"22","author":"S Esfandyari","year":"2021","unstructured":"Esfandyari, S., Elkafas, H., Chugh, R. M., Park, H. S., Navarro, A., & Al-Hendy, A. Exosomes as biomarkers for female reproductive diseases diagnosis and therapy. Int. J. Mol. Sci. 22, 2165 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"86794_CR11","first-page":"e21781","volume":"14","author":"N Mishra","year":"2022","unstructured":"Mishra, N., Verma, R. & Jadaun, P. Study on the effect of berberine, myoinositol, and metformin in women with polycystic ovary syndrome: A prospective randomised study. Cureus 14, e21781 (2022).","journal-title":"Cureus"},{"key":"86794_CR12","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/nu15143130","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. The Association between circulating lipids and female infertility risk: A univariable and multivariable Mendelian randomization analysis. Nutrients 15, 3130 (2023).","journal-title":"Nutrients"},{"key":"86794_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/humrep\/dex052","volume":"32","author":"SJ Pugh","year":"2017","unstructured":"Pugh, S. J. et al. Preconception maternal lipoprotein levels in relation to fecundability. Hum. Reprod. 32, 1055\u20131063 (2017).","journal-title":"Hum. Reprod."},{"key":"86794_CR14","doi-asserted-by":"publisher","first-page":"1153986","DOI":"10.3389\/fnut.2023.1153986","volume":"10","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Dietary fats and serum lipids in relation to the risk of ovarian cancer: a meta-analysis of observational studies. Front. Nutr. 10, 1153986 (2023).","journal-title":"Front. Nutr."},{"key":"86794_CR15","doi-asserted-by":"publisher","first-page":"114526","DOI":"10.1016\/j.biopha.2023.114526","volume":"161","author":"J Li","year":"2023","unstructured":"Li, J., Yang, H., Zhang, L., Zhang, S. & Dai, Y. Metabolic reprogramming and interventions in endometrial carcinoma. Biomed. Pharmacother. 161, 114526 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"86794_CR16","doi-asserted-by":"publisher","first-page":"1295412","DOI":"10.3389\/fendo.2023.1295412","volume":"14","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Causal association between lipid-lowering drugs and female reproductive endocrine diseases: A drug-targeted Mendelian randomization study. Front. Endocrinol. (Lausanne). 14, 1295412 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"86794_CR17","doi-asserted-by":"publisher","first-page":"e7325","DOI":"10.1136\/bmj.e7325","volume":"345","author":"S Burgess","year":"2012","unstructured":"Burgess, S., Butterworth, A., Malarstig, A. & Thompson, S. G. Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ 345, e7325 (2012).","journal-title":"BMJ"},{"key":"86794_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synth. Methods. 10, 486\u2013496 (2019).","journal-title":"Res. Synth. Methods"},{"key":"86794_CR19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"GD Smith","year":"2014","unstructured":"Smith, G. D. & Hemani, G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u201398 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"86794_CR20","unstructured":"Burgess, S. & Thompson, S. G. Mendelian randomization: Methods for using genetic variants in causal estimation (2nd Edition). (Chapman and Hall\/CRC, 2021)."},{"key":"86794_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13048-023-01306-y","volume":"16","author":"R Cao","year":"2023","unstructured":"Cao, R. et al. Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: A multivariable Mendelian randomization analysis. J. Ovarian Res. 16, 215 (2023).","journal-title":"J. Ovarian Res."},{"key":"86794_CR22","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/bioinformatics\/btv285","volume":"31","author":"L Aimo","year":"2015","unstructured":"Aimo, L. et al. The SwissLipids knowledgebase for lipid biology. Bioinformatics 31, 2860\u20132866 (2015).","journal-title":"Bioinformatics"},{"key":"86794_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample Mendelian randomization. Genet. Epidemiol. 40, 597\u2013608 (2016).","journal-title":"Genet. Epidemiol."},{"key":"86794_CR24","doi-asserted-by":"publisher","first-page":"1154746","DOI":"10.3389\/fimmu.2023.1154746","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Inflammatory bowel diseases, interleukin-6 and interleukin-6 receptor subunit alpha in causal association with cerebral cortical structure: A Mendelian randomization analysis. Front. Immunol. 14, 1154746 (2023).","journal-title":"Front. Immunol."},{"key":"86794_CR25","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sim.4197","volume":"30","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat. Med. 30, 1312\u20131323 (2011).","journal-title":"Stat. Med."},{"key":"86794_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and disease. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"86794_CR27","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41598-024-56946-x","volume":"14","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. Lipid levels and risk of acute pancreatitis using bidirectional Mendelian randomization. Sci. Rep. 14, 6267 (2024).","journal-title":"Sci. Rep."},{"key":"86794_CR28","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Smith, G. D. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018).","journal-title":"BMJ"},{"key":"86794_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations: Update for summer 2023. Wellcome Open. Res. 4, 186 (2023).","journal-title":"Wellcome Open. Res."},{"key":"86794_CR30","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/sim.9133","volume":"40","author":"E Sanderson","year":"2021","unstructured":"Sanderson, E., Spiller, W. & Bowden, J. Testing and correcting for weak and pleiotropic instrumentsin two-sample multivariable Mendelian randomization. Stat. Med. 40, 5434\u20135442 (2021).","journal-title":"Stat. Med."},{"key":"86794_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12944-023-01877-1","volume":"22","author":"J Cao","year":"2023","unstructured":"Cao, J. et al. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: A Mendelian randomization and mediation analysis. Lipids Health Dis. 22, 110 (2023).","journal-title":"Lipids Health Dis."},{"key":"86794_CR32","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani, G., Bowden, J. & Smith, G. D. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum. Mol. Genet. 27, R195\u2013R208 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"86794_CR33","doi-asserted-by":"publisher","first-page":"e0287125","DOI":"10.1371\/journal.pone.0287125","volume":"19","author":"T Yin","year":"2024","unstructured":"Yin, T. et al. The causal relationship between 25-hydroxyvitamin D and serum lipids levels: A bidirectional two-sample Mendelian randomization study. PLoS One. 19, e0287125 (2024).","journal-title":"PLoS One"},{"key":"86794_CR34","doi-asserted-by":"publisher","first-page":"731569","DOI":"10.3389\/fendo.2021.731569","volume":"12","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: A Mendelian randomization study. Front. Endocrinol. (Lausanne). 12, 731569 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"86794_CR35","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1038\/s41598-024-55993-8","volume":"14","author":"S Ling","year":"2024","unstructured":"Ling, S. et al. Epidemiologic and genetic associations of female reproductive disorders with depression or dysthymia: A Mendelian randomization study. Sci. Rep. 14, 5984 (2024).","journal-title":"Sci. Rep."},{"key":"86794_CR36","doi-asserted-by":"publisher","first-page":"e1003679","DOI":"10.1371\/journal.pmed.1003679","volume":"19","author":"SS Venkatesh","year":"2022","unstructured":"Venkatesh, S. S. et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. PLoS Med. 19, e1003679 (2022).","journal-title":"PLoS Med."},{"key":"86794_CR37","doi-asserted-by":"publisher","first-page":"1161356","DOI":"10.3389\/fendo.2023.1161356","volume":"14","author":"B Zhao","year":"2023","unstructured":"Zhao, B., Wang, Z., Liu, D. & Zhang, S. Genetically predicted serum testosterone and risk of gynecological disorders: A Mendelian randomization study. Front. Endocrinol. (Lausanne). 14, 1161356 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"86794_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter, A. R. et al. Mendelian randomisation for mediation analysis: Current methods and challenges for implementation. Eur. J. Epidemiol. 36, 465\u2013478 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"86794_CR39","doi-asserted-by":"publisher","first-page":"22184","DOI":"10.1038\/s41598-022-25041-4","volume":"12","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Gut microbiome in PCOS associates to serum metabolomics: A cross-sectional study. Sci. Rep. 12, 22184 (2022).","journal-title":"Sci. Rep."},{"key":"86794_CR40","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1002\/jcp.30309","volume":"236","author":"Z Mao","year":"2021","unstructured":"Mao, Z. et al. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome. J. Cell. Physiol. 236, 6362\u20136375 (2021).","journal-title":"J. Cell. Physiol."},{"key":"86794_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","volume":"185","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients. J. Steroid Biochem. Mol. Biol. 185, 142\u2013149 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"86794_CR42","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00018-012-0917-5","volume":"69","author":"BT Bikman","year":"2012","unstructured":"Bikman, B. T. A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cell. Mol. Life Sci. 69, 2135\u20132146 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"86794_CR43","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3390\/jcm10132811","volume":"10","author":"K Ozegowska","year":"2021","unstructured":"Ozegowska, K., Plewa, S., Mantaj, U., Pawelczyk, L. & Matysiak, J. Serum metabolomics in PCOS women with different body mass index. J. Clin. Med. 10, 2811 (2021).","journal-title":"J. Clin. Med."},{"key":"86794_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/JME-17-0023","volume":"59","author":"LJ Moran","year":"2017","unstructured":"Moran, L. J., Mundra, P. A., Teede, H. J. & Meikle, P. J. The association of the lipidomic profile with features of polycystic ovary syndrome. J. Mol. Endocrinol. 59, 93\u2013104 (2017).","journal-title":"J. Mol. Endocrinol."},{"key":"86794_CR45","doi-asserted-by":"publisher","first-page":"1164186","DOI":"10.3389\/fendo.2023.1164186","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang, Y. et al. Gut microbiome and reproductive endocrine diseases: A Mendelian randomization study. Front. Endocrinol. (Lausanne). 14, 1164186 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"86794_CR46","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1093\/humrep\/des152","volume":"27","author":"K Vouk","year":"2012","unstructured":"Vouk, K. et al. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum. Reprod. 27, 2955\u20132965 (2012).","journal-title":"Hum. Reprod."},{"key":"86794_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphys.2018.00014","volume":"9","author":"J Li","year":"2018","unstructured":"Li, J. et al. Discovery of phosphatidic acid, phosphatidylcholine, and phosphatidylserine as biomarkers for early diagnosis of endometriosis. Front. Physiol. 9, 14 (2018).","journal-title":"Front. Physiol."},{"key":"86794_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/path.6079","volume":"260","author":"Y Dai","year":"2023","unstructured":"Dai, Y. et al. Integrative analysis of transcriptomic and metabolomic profiles reveals abnormal phosphatidylinositol metabolism in follicles from endometriosis-associated infertility patients. J. Pathol. 260, 248\u2013260 (2023).","journal-title":"J. Pathol."},{"key":"86794_CR49","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1021\/acs.jproteome.6b00197","volume":"15","author":"M Dutta","year":"2016","unstructured":"Dutta, M. et al. Metabolomics reveals altered lipid metabolism in a mouse model of endometriosis. J. Proteome Res. 15, 2626\u20132633 (2016).","journal-title":"J. Proteome Res."},{"key":"86794_CR50","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.redox.2023.102861","volume":"66","author":"LC Lin","year":"2023","unstructured":"Lin, L. C. et al. Oxidative stress mediates the inhibitory effects of Manzamine A on uterine leiomyoma cell proliferation and extracellular matrix deposition via SOAT inhibition. Redox Biol. 66, 102861 (2023).","journal-title":"Redox Biol."},{"key":"86794_CR51","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1177\/1933719116689598","volume":"24","author":"A Vignini","year":"2017","unstructured":"Vignini, A. et al. Preperitoneal fat thicknesses, lipid profile, and oxidative status in women with uterine fibroids. Reprod. Sci. 24, 1419\u20131425 (2017).","journal-title":"Reprod. Sci."},{"key":"86794_CR52","doi-asserted-by":"publisher","first-page":"53994","DOI":"10.1074\/jbc.M410144200","volume":"279","author":"M Yamanaka","year":"2004","unstructured":"Yamanaka, M. et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. J. Biol. Chem. 279, 53994\u201354001 (2004).","journal-title":"J. Biol. Chem."},{"key":"86794_CR53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/humupd\/dmad009","volume":"29","author":"IM McGrath","year":"2023","unstructured":"McGrath, I. M., Montgomery, G. W. & Mortlock, S. Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities. Hum. Reprod. Update. 29, 655\u2013674 (2023).","journal-title":"Hum. Reprod. Update"},{"key":"86794_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11154-023-09826-0","volume":"25","author":"N Salmeri","year":"2024","unstructured":"Salmeri, N., Vigano, P., Cavoretto, P., Marci, R. & Candiani, M. The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome. Rev. Endocr. Metab. Disord. 25, 239\u2013257 (2024).","journal-title":"Rev. Endocr. Metab. Disord"},{"key":"86794_CR55","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3724\/abbs.2022076","volume":"54","author":"T Zhao","year":"2022","unstructured":"Zhao, T. et al. Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating the TGF\/beta-Smad2\/3 signaling pathway. Acta Biochim. Biophys. Sin (Shanghai). 54, 904\u2013916 (2022).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"86794_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-021-02211-2","volume":"41","author":"X Mao","year":"2022","unstructured":"Mao, X. et al. Lipid reprogramming induced by the TFEB-ERRalpha axis enhanced membrane fluidity to promote EC progression. J. Exp. Clin. Cancer Res. 41, 28 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"86794_CR57","first-page":"687","volume":"25","author":"SE Antmen","year":"2021","unstructured":"Antmen, S. E., Canacankatan, N., Gurses, I., Aytan, H. & Erturk, S. E. Relevance of lipogenesis and AMPK\/Akt\/mTOR signaling pathway in endometr\u0131al cancer. Eur. Rev. Med. Pharmacol. Sci. 25, 687\u2013695 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"86794_CR58","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.3892\/or.2014.3521","volume":"32","author":"L Lin","year":"2014","unstructured":"Lin, L. et al. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Oncol. Rep. 32, 2831\u20132835 (2014).","journal-title":"Oncol. Rep."},{"key":"86794_CR59","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1210\/jc.2019-00793","volume":"104","author":"J Li","year":"2019","unstructured":"Li, J. et al. Lipid profiling of peri-implantation endometrium in patients with premature progesterone rise in the late follicular phase. J. Clin. Endocrinol. Metab. 104, 5555\u20135565 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"86794_CR60","first-page":"505","volume":"18","author":"P Li","year":"2006","unstructured":"Li, P. et al. Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. Int. J. Mol. Med. 18, 505\u2013510 (2006).","journal-title":"Int. J. Mol. Med."},{"key":"86794_CR61","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/2159-8290.CD-13-0159","volume":"3","author":"M Nishimura","year":"2013","unstructured":"Nishimura, M. et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 3, 1302\u20131315 (2013).","journal-title":"Cancer Discov"},{"key":"86794_CR62","doi-asserted-by":"publisher","first-page":"114048","DOI":"10.1016\/j.jpba.2021.114048","volume":"199","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Serum lipid profiling analysis and potential marker discovery for ovarian cancer based on liquid chromatography-Mass spectrometry. J. Pharm. Biomed. Anal. 199, 114048 (2021).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"86794_CR63","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization (STROBE-MR) statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"86794_CR64","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ 375, n2233 (2021).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86794-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T22:40:13Z","timestamp":1737326413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86794-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86794-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data used in this study were sourced from publicly available datasets, originally collected from studies that had received prior approval from an ethics committee for human experimentation. Therefore, our study did not require additional ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"2448"}}